Quick Dispatch:
Your hengrui glp 1 Kailera, Hengrui to advance oral obesity drug into 2 new trials orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your hengrui glp 1 Kailera, Hengrui to advance oral obesity drug into 2 new trials ships.
Need Help?
Questions about hengrui glp 1 Kailera, Hengrui to advance oral obesity drug into 2 new trials, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for hengrui glp 1 Kailera, Hengrui to advance oral obesity drug into 2 new trials in your area.
Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 | Tue, 11/04/2025
29.66
Hengrui, Kailera tout positive results for dual-acting obesity pill
20.17
Jiangsu Hengrui Competitive Landscape Analysis 2026
27.63
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
26.81
GSK forges $12bn alliance with China's Hengrui
23.35
Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1 Portfolio // Cooley // Global Law Firm
29.28
GLP-1 Receptor Agonist Market Size, Trends and Share Report 2026
27.84
